Media Releases

Downloads

Roche Launches Ocrevus® (Ocrelizumab) -a Breakthrough Blockbuster Therapy, Redefining Multiple Sclerosis (MS) Treatment in IndiaRoche unveils its first ever Customer Experience Center in ChennaiRoche and ZS partner to set up dedicated center in ChennaiRoche Pharma India Launches Patient Support App To Help Patients Seamlessly Navigate Their Care JourneyRoche expands its Global Analytics and Technology Center of ExcellenceRoche's Evrysdi (Risdiplam) - the first and only oral treatment for adults and children two months or older suffering from Spinal Muscular Atrophy (SMA) now available in IndiaRoche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-IndiaRoche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19Company statement on Tocilizumab (Brand: Actemra) suppliesRoche launches new therapy Emicizumab for people with Hemophilia A on World Hemophilia DayRoche and St. Jude India ChildCare Centre come together with Dr. B Barooah Cancer Institute to offer holistic cancer care to underprivileged children
©  Roche Products (India) Pvt. Ltd.  

Disclaimer: The images on this website are for representation purpose only and do not indicate actual patient outcomes or the effects of any product.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, visit us atOR please call the Roche India Safety Unit onor E-mail us at